FigureAsia 35 Under 35 · Healthcare
Yo Nakahara
Age 31 · Ambient clinical documentation · Tokyo, Japan
Physician-founder whose service reports use by more than 1,000 institutions and about 50,000 documents a week, with a 2025 hospital validation reporting roughly 2,000 hours saved over three months.
- Approximate age at 31 December 2025
- 31
- Field
- Healthcare
- Country or region
- Tokyo, Japan
- FigureAsia U35 Assessment
- 88.9 / 100
Profile
Career and documented record
Yo Nakahara is building around a burden that clinicians understand immediately: the time consumed by documentation after the encounter. The ambient system he cofounded converts clinical conversation into structured notes for clinician review. By 2025–2026, the company reported use by more than 1,000 institutions and production of roughly 50,000 documents each week.
A 2025 validation with a hospital group reported approximately 2,000 hours saved over three months. The result is operational rather than clinical, but time returned to care teams can be consequential in a system facing workforce pressure. Nakahara's role as both physician and company president gives him responsibility for product design, workflow fit and the safety of how generated text enters the record.
The scale and time-saving figures are organization or partner-reported, and solo credit must be understood within a three-person founding team. Ambient documentation can introduce omissions, hallucinations and privacy risk; every note still requires accountable clinical review. Nakahara's inclusion recognizes documented adoption and a measurable workflow result, not autonomous medical authorship.
FigureAsia selection
Why Yo Nakahara is on the list
FigureAsia selected Nakahara because his company has moved ambient documentation beyond a demonstration into wide reported use and a specific hospital time study. His clinical background and executive role establish substantial agency, while the profile preserves credit for the wider founding team. The score rewards translation and workforce relevance and is constrained by self-reported scale and limited independent error analysis.
Verified work
The 2025–26 record
Principal milestone
More than 1,000 institutions reported
Evidence record
Approximately 50,000 documents per week reported
Scale or implementation
Roughly 2,000 hours saved over three months in a 2025 partner validation
Field context
The work in its field
Within ambient clinical documentation, the relevant test is whether a result can survive scrutiny of maturity, attribution, validity and practical fit. That distinction matters: completed evidence is not projected benefit, and individual responsibility is not interchangeable with the wider team’s achievement.
FigureAsia U35 Assessment
Assessment breakdown
88.9out of 100
Substantive 2025–2026 contribution
18 / 20
The score reflects completed 2025–26 work in ambient clinical documentation, assessed at the documented maturity of deployed clinical documentation software.
Verified impact
13.5 / 15
Impact credit is limited to the measured study, regulatory, implementation or operating record stated in the profile; unsupported patient benefit is excluded.
Originality and distinction
9 / 10
The work creates or materially advances a distinctive capability within ambient clinical documentation rather than relying on title or institutional association.
Field and industry influence
8 / 10
The assessment recognises demonstrated effects on research, product development, care delivery or professional practice, with publicity alone carrying no weight.
Individual agency
9 / 10
Named authorship and the documented role of Cofounder, President and Physician establish individual responsibility while preserving credit for collaborators.
Durability and trajectory
4 / 5
The cited work forms part of a continuing programme, platform or research trajectory rather than a single uncompleted announcement.
Asian significance and global relevance
5 / 5
The Asian connection is material to the person's identity, operating base or populations served: Japanese physician-founder building clinical documentation infrastructure in Japan.
Clinical and scientific validity
5.6 / 7
Clinical and scientific validity is calibrated to deployed clinical documentation software, with the profile retaining the evidence boundary attached to the result.
Safety, quality and responsible governance
6.3 / 7
Safety and governance credit reflects accurate regulatory language, study limitations, data stewardship and the refusal to turn early evidence into clinical certainty.
Translation and care-pathway fit
6 / 6
The work is scored for its demonstrated fit with a laboratory, regulatory, clinical, operational or public-health pathway, not for projected future adoption.
Access, equity and resource stewardship
4.5 / 5
Access credit reflects documented reach, capacity, affordability or inclusion while distinguishing service volume from proven clinical outcome.